Waters Corporation (WAT)
NYSE · Healthcare · Diagnostics & Research
Waters Corporation is a Healthcare company with a market capitalization of $36.76B and a trailing P/E ratio of 47.6.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 5, 2026 | $2.70 | $2.31 | +16.9% |
| Q4 2025 | February 9, 2026 | $4.53 | $4.51 | +0.4% |
| Q3 2025 | November 4, 2025 | $2.50 | $2.99 | -16.4% |
| Q2 2025 | August 4, 2025 | $2.95 | $2.94 | +0.3% |
| Q1 2025 | May 6, 2025 | $2.25 | $2.22 | +1.4% |
| Q4 2024 | February 12, 2025 | $4.10 | $4.03 | +1.7% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Waters Corporation's market cap?
As of June 29, 2026, Waters Corporation (WAT) has a market capitalization of $36.76B.
What is Waters Corporation's P/E ratio?
Waters Corporation trades at a trailing price-to-earnings (P/E) ratio of 47.6. Its forward P/E is 26.1.
Does Waters Corporation pay a dividend?
Waters Corporation does not currently pay a dividend.
What sector is WAT in?
Waters Corporation is in the Healthcare sector, specifically the Diagnostics & Research industry.
What was Waters Corporation's revenue?
In its latest reported fiscal year (ending December 31, 2025), Waters Corporation reported revenue of $3.17B and net income of $642.63M.
Ask your own questions about WAT
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.